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The establishment of the primitive streak and its derivative germ
layers, mesoderm and endoderm, are prerequisite steps in the
formation of many tissues. To model these developmental stages
in vitro, an ES cell line was established that expresses CD4 from the
foxa2 locus in addition to GFP from the brachyury locus. A GFP-Bry
population expressing variable levels of CD4-Foxa2 developed
upon differentiation of this ES cell line. Analysis of gene-expres-
sion patterns and developmental potential revealed that the CD4-
Foxa2hiGFP-Bry population displays characteristics of the anterior
primitive streak, whereas the CD4-Foxa2loGFP-Bry cells resemble
the posterior streak. Using this model, we were able to demon-
strate that Wnt and TGF-nodalactivin signaling simultaneously
were required for the generation of the CD4-Foxa2GFP-Bry
population. Wnt or low levels of activin-induced a posterior prim-
itive streak population, whereas high levels of activin resulted in
an anterior streak fate. Finally, sustained activin signaling was
found to stimulate endoderm commitment from the CD4-
Foxa2GFP-Bry ES cell population. These findings demonstrate
that the early developmental events involved in germ-layer induc-
tion in the embryo are recapitulated in the ES cell model and
uncover insights into the signaling pathways involved in the
establishment of mesoderm and endoderm.
gastrulation  mesoderm  endoderm
To be able to fully exploit the potential of embryonic stem (ES)cells in basic biology and regenerative medicine, it is essential
to recapitulate the critical lineage induction events of the early
embryo in this model system. One of the earliest commitment steps
in embryogenesis is the formation of the primary germ layers,
mesoderm, endoderm, and ectoderm, the founder populations of
all somatic cell types in the body (1). Mesoderm and endoderm are
formed during gastrulation, a process that involves the movement
of undifferentiated epiblast cells through a structure called the
primitive streak (PS). The PS can be subdivided into distinct
regions, posterior, middle, and anterior, based on lineage develop-
ment and gene-expression patterns. With respect to developmental
potential, distinct subpopulations of mesoderm are induced in each
of the different regions, whereas definitive endoderm forms from
the anterior PS of the early-PS and mid-PS stages (2–5). These
observations suggest that the different regions of the PS constitute
different signaling environments that are responsible for the in-
duction of specific lineages.
To address questions regarding early commitment by using the
ES cell model, it is essential to be able to track and isolate
germ-layer populations from the differentiation cultures. By using
an ES cell line with the green fluorescence protein (GFP) targeted
to the PS and early mesodermal-specific gene brachyury (6) (GFP-
Bry ES cells), it has been possible to quantify mesoderm induction
and isolate and characterize different mesodermal populations
(7, 8). In addition, brachyury-expressing cells were found to give rise
to endoderm derivatives (9). Endoderm was induced with a high
concentration of activin A, a factor that binds the same receptor as
nodal and likely mimics nodal signaling. Recent studies have
confirmed the endoderm-inducing properties of activin in mouse
ES cell differentiation cultures (10, 11). The ability of activin to
induce endoderm is not restricted to mouse cells as it has been
shown to induce similar populations in human ES cell differentia-
tion cultures (12). These observations illustrate the utility of using
appropriately marked ES cells for monitoring the earliest induction
events in differentiation cultures and identifying the molecules that
regulate them.
To further investigate the earliest stages of mesoderm and
endoderm formation in the ES cell model, we targeted the human
CD4 cDNA to the foxa2 locus in the GFP-Bry ES cells. Foxa2 was
selected as it is expressed in the anterior PS, containing definitive
endoderm precursors, as well as in most mature endoderm-derived
tissues (13–15). In this article, we demonstrate that this ES cell line
can be used to isolate cell populations with gene-expression profiles
and developmental potentials similar to the posterior and anterior
PS of the embryo.We also show that activation of both theWnt and
nodal signaling pathways are required together for the formation of
PS like cells in the ES cell differentiation cultures. Finally, we have
uncovered two distinct roles for activin signaling in early germ-layer
formation. The first is the induction of the PS population, and the
second is in the specification of endoderm from the PS.
Results
Generation of an ES Cell Line That Expresses Human CD4 from the
Foxa2 Locus. The foxa2 targeting construct (Fig. 6A, which is
published as supporting information on the PNAS web site) con-
tains a truncated version of the human CD4 cDNA that lacks most
of the intracellular signaling domain (16). GFP-Bry ES cells were
electroporated with the foxa2 targeting vector, and appropriately
targeted clones were identified by Southern blot analysis (Fig. 1A).
Two targeted clones were generated and transiently transfected
with a Cre recombinase expression vector to remove the puro gene.
Both clones had a normal karyotype. The targeted clones are
hereinafter referred to as CD4-Foxa2GFP-Bry ES cells.
CD4 was expressed at low to undetectable levels on undiffer-
entiated ES cells (Fig. 1B). A kinetic analysis of serum-induced
embryoid body (EB) differentiation revealed that the levels of
CD4 increased concurrently with the onset of GFP-Bry expres-
sion, and by day 3 all GFP cells expressed CD4. By day 3.5 of
differentiation, CD4 expression decreased substantially and
continued to decline to undetectable levels by day 5. GFP
expression persisted at high levels to day 4 and then showed a
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sharp reduction by day 5 [displayed as mean fluorescence
intensity (MFI)] (Fig. 6 B). The expression of endogenous foxa2
and brachyury paralleled the patterns of CD4 and GFP, respec-
tively (Fig. 6C). To further characterize the CD4 expression
pattern, chimeric mice were generated with CD4-Foxa2GFP-
Bry ES cells, and the resulting gastrulating embryos were
costained for CD4 and Foxa2 (Fig. 7A, which is published as
supporting information on the PNAS web site). CD4 expression
colocalized with Foxa2 in the anterior PS, whereas it was absent
from the anterior visceral endoderm. This is the expected
pattern because ES cells do not contribute to extra-embryonic
endoderm (17). These findings demonstrate that CD4 expression
recapitulates expression of foxa2 both in vitro and in vivo and, as
such, provides a valid marker for monitoring anterior PS and
endoderm development.
Modeling PS Development by Using the CD4-Foxa2GFP-Bry ES Cell
Line.During serum-induced differentiation, GFP expression varied
over a relatively narrow range (1 log), whereas the expression
pattern of CD4-Foxa2 was broad, showing a 2-log difference in
levels (Fig. 1B). One interpretation of this pattern is that the
brachyury-expressing population is the EB equivalent of the PSwith
the CD4-Foxa2hi- and CD4-Foxa2lo-expressing cells representing
the anterior and posterior regions of the streak, respectively.
Consistent with this interpretation is the observation that other
genes found in and around the PS, including cer1, gsc, hoxB1, evx1,
wnt3, and nodal (5, 18–21), were expressed in the EBs at the same
stage that brachyury and foxa2were expressed (Fig. 6C). In contrast,
expression of the ectodermalmarker Pax6 (22) was down-regulated
with the onset of brachyury and foxa2 expression. To test the
interpretation that the CD4-Foxa2 subpopulations represent dif-
ferent regions of the PS, CD4hiGFP, CD4medGFP, and
CD4loGFP fractions were isolated by cell sorting (Fig. 2C) and
compared with the posterior, middle, and anterior PS regions from
embryonic day 7.25 embryos (Fig. 2A) by gene-expression analyses.
The known posterior PS genes evx1, hoxB1, and tbx6 (23) were
expressed in the posterior, middle, and anterior regions of the
mouse PS in a pattern similar to that found in the CD4loGFP,
CD4medGFP, and CD4hiGFP fractions (Fig. 2 B and D). In
addition, the anterior PS markers cer1, gsc, and foxa2 showed
highest expression in the anterior PS or CD4hiGFP cells. The
pattern of foxa2 expression corresponds well to CD4 levels. To
determine whether the differences in message levels reflect differ-
ences in Foxa2 protein, CD4hi and CD4lo cells were stained with an
anti-Foxa2 antibody (Fig. 7B). Foxa2was detected only in theCD4hi
population. The striking similarity in the expression patterns of
these genes in the different regions of the PS and the EB-derived
populations supports the interpretation that the CD4-Foxa2GFP-
Bry-expressing EB population represents the in vitro equivalent of
the PS.
Developmental Potential of Different CD4-Foxa2-Expressing Popula-
tions. The posterior and anterior regions of the mouse PS display
different developmental potentials. At the mid-PS stage, the pos-
terior region gives rise to the yolk sac, whereas the anterior PS forms
endoderm and anteriormesoderm, including the cardiac lineage (4,
24). To determine whether the different CD4-expressing popula-
tions display developmental potentials similar to the different
regions of the PS, CD4lo/medGFP, and CD4hiGFP populations
isolated fromday 3.25EBswere assayed for hematopoietic, cardiac,
and endoderm potential. As shown in Fig. 3A, the CD4loGFP
population contained significantly more hematopoietic progenitors
Fig. 1. Targeting human CD4 to the Foxa2 locus. (A) Southern blot analysis
depicting a targeted clone (#19). (B) Flow cytometric analysis of CD4-Foxa2
and GFP-Bry expression in EBs differentiated for varying periods of time. Day
0 is undifferentiated ES cells. Control represents unstained ES cells.
Fig. 2. Gene-expression analysis of regions of the PS and CD4-Foxa2GFP-Bry EB subpopulations. (A) An embryonic day 7.25 mouse GFP-Bry embryo expressing
GFP in the PS. Boxes indicate the posterior (Pos), middle (Mid), and anterior (Ant) PS regions. (B) RT-PCR gene-expression analysis of the different regions of the
PS. (C) The presort (Pre), CD4loGFP (CD4 Lo), CD4medGFP (CD4 Med), and CD4hiGFP (CD4 Hi) populations were isolated by cell sorting from day 3.25
serum-stimulated EBs. (D) RT-PCR gene-expression analysis of the CD4 Lo, CD4 Med, and CD4 Hi populations.
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than the CD4hiGFP population. To assess cardiac potential, the
development of contracting cells within aggregates was determined
as described (8). Cardiac potential was restricted to theCD4hiGFP
population (Fig. 3B). The unsorted population also failed to yield
contracting aggregates, suggesting that there is a CD4 low or
negative population that is inhibitory for cardiac differentiation. To
assay endodermdevelopment, the cardiac culturesweremaintained
under serum-free conditions for an additional 5 days, and
endoderm-specific gene expressionwas analyzed. The expression of
hnf4, aat, and alb1, genes associated with hepatocyte specification
and pdx1, a marker of early pancreatic development (25, 26), was
detected only in the populations generated from the CD4hiGFP
aggregates, confirming the endoderm potential of these cells (Fig.
3C). Taken together, these findings add support to the interpreta-
tion that serum-induced CD4GFP cells represent a population
with potential similar to the PS of the embryo. Hereafter, the entire
CD4GFP population will be referred to as the ES cell PS
population.
Both Wnt and TGF- Family Members Are Required for ES Cell PS
Induction. Studies in mice and other organisms have demonstrated
the importance of the Wnt and nodal signaling pathways in gas-
trulation and in endoderm andmesoderm induction (20, 21, 27, 28).
Expression of both Wnt3 and nodal was induced in the serum-
stimulated EBs (Fig. 6C), suggesting that these factors also may be
involved in the development of the ES cell PS population. To
investigate this possibility, Wnt signaling was inhibited in the
cultures by the addition of DKK1, and TGF-nodalactivin sig-
naling was blocked by the addition of the small molecule inhibitor
SB-431542 (SB). DKK1 functions by binding the Wnt coreceptors
LRP5 and LRP6, which are essential for activation of the -catenin
signaling pathway (29). SB is a specific inhibitor of the receptors
ALK4, ALK5, and ALK7 (30) and thus is able to block TGF-,
activin, and nodal but not bone morphogenic protein signaling.
Addition of high concentrations of either SB (10 M) or DKK1
(150 ngml) completely blocked the development of the serum-
induced ES cell PS population as determined by GFP versus CD4
flow cytometric profile and PS gene expression (Fig. 8, which is
published as supporting information on the PNASweb site). Lower
concentrations of DKK1 (15 ngml) led to a modest increase in the
proportion of CD4hiGFP cells and a concomitant decrease in the
CD4loGFP population (Fig. 8A). In contrast, the addition of low
concentrations of SB (2 M) to the cultures blocked the develop-
ment of the CD4hiGFP but not the CD4loGFP population (Fig.
8A). These data suggest that both Wnt and TGF- pathways are
required for ES cell PS development.
To determine whether activation of theWnt and TGF-nodal
activin pathways is sufficient to induce the development of the ES
cell PS population in the absence of other serum-derived factors, ES
cells were differentiated either in the presence of Wnt3a or activin
A in serum-free cultures. Activin was used as a surrogate of nodal
as it can signal through the same receptor as nodal but is not
affected by Lefty1, an inhibitor of nodal (31) that is expressed in the
developing EBs (data not shown). We previously have demon-
strated that activin can induce both mesoderm and endoderm in
serum-free cultures (9). Here, we use an improved serum-free
media that supports efficient EB formation and activin-induced
CD4-Foxa2 and GFP-Bry expression (data not shown). For all
studies detailed below, EB formation was initiated in serum-free
media in the absence of factors. At day 2, the various inducers or
inhibitors of differentiation were added as described below.
Both activin (25 ngml) and Wnt (100 ngml) induced the
formation of the CD4-Foxa2GFP-Bry population, whereas no
significant levels of GFP developed in the absence of factors (Fig.
4A). This concentration of activin stimulation resulted in the
generation of a population of cells that expressed GFP and high
levels of CD4. In contrast, the GFP population induced with Wnt
displayed lower levels of CD4.Activin induced the expression of the
anterior PSmarkers gsc and cer1 (Fig. 4C), whereasWnt was a poor
inducer of these markers but did induce expression of the posterior
PS markers hoxB1 and tbx6. These findings indicate that activin (25
ngml) induced predominantly the ES cell anterior PS population,
and Wnt induced the development of the posterior PS.
To further investigate the role of the strength of TGF-nodal
activin signaling, ES cells were stimulated with a lower dose (1
ngml) of activin (Fig. 4A). This concentration of activin induced
a CD4-Foxa2GFP-Bry population that expressed relatively low
levels of CD4. As expected from the CD4 expression pattern, 1
ngml of activin induced the posteriormarkers hoxB1 and tbx6 (Fig.
4C). These data confirm the inhibition studies shown in Fig. 8 and
suggest that a strong TGF-nodalactivin signal favors an anterior
fate, whereas a weaker signal induces the development of a more
posterior population.
To confirm the requirement of Wnt and activinnodal signaling
in PS formation from ES cells, downstream effectors of these
pathways were inhibited by using RNA interference (32). To
examine the requirement for Wnt signaling, a short hairpin RNA
(shRNA) against -catenin was introduced into day 2 EBs cells
before addition of low levels of activin andWnt. Introduction of this
hairpin completely blocked GFP-Bry induction (Fig. 9A, which is
published as supporting information on the PNAS web site). To
block activinnodal signaling, shRNAs against smad2 and smad3
were used. Introduction of these hairpins individually led to a
decrease in GFP-Bry levels, whereas the combination of both
hairpins blocked the expression of GFP-Bry. A titration of Smad2
shRNA was used to attenuate activinnodal signaling in EBs
stimulated with higher levels of activin (Fig. 9B). As more shRNA
was added to the cultures, there was a progressive loss of CD4-
Foxa2hi cells and a general decrease in CD4 levels as indicated by
Fig. 3. The functional potential of the CD4loGFP and CD4hiGFP popula-
tions. CD4loGFPand CD4hiGFP cells were isolated from serum-induced EBs as
indicated in Fig. 2 and analyzed as described below. (A) Isolated populations
were reaggregated for 24 h in serum-free media and then assayed for hema-
topoietic potential by colony assay. The number of primitive erythroid (filled
bars), macrophage (hatched bars), and macrophageerythroid (open bars)
colonies were counted after 5–7 days of culture. Data are presented as mean
number of colonies from three cultures. Bars represent SEM. (B) Isolated
populations were reaggregated in serum-free media for 24 h, and the aggre-
gates were allowed to adhere onto matrigel-coated dishes in serum-free
media. The proportion of aggregates with contracting cells was scored 1–2
days later. (C) Aggregates were maintained for 7 days on matrigel-coated
dishes in serum-free media, and gene expression was analyzed by RT-PCR.
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MFI. These data confirm that Wnt and activinnodal signaling are
required for ES cell PS development and that decreasing levels of
activin signaling lead to a preferential decrease in anterior PS cells.
Although mutations in either wnt3 or nodal completely block
gastrulation and PS induction in vivo, the exact role for each is
unclear, considering that wnt3 mutants lack nodal expression (20).
In the serum-freeES cell differentiation system,Wnt induced nodal
and activin induced wnt3 (Fig. 4C), suggesting that both signaling
pathways are involved in the development of the CD4-Foxa2GFP-
Bry-expressing population. To further investigate the role of the
Wnt and TGF-nodalactivin pathways in the induction of the ES
cell PS, either activin or Wnt were added to the differentiation
cultures with either SB or DKK1 (Fig. 4B). Both inhibitors com-
pletely blocked the development of CD4-Foxa2GFP-Bry cells
with either inducer. None of the other PSmarkers (gsc, cer1, hoxB1,
and tbx6) were expressed in cells treatedwith either of the inhibitors
(Fig. 4C). To determine whether activin acted earlier than Wnt in
the induction of the CD4-Foxa2GFP-Bry population, the day 2
EBs were incubated with activin and DKK1 for 20 h, washed, and
then incubated with Wnt and SB. No CD4-Foxa2GFP-Bry cells
developed after the sequential activation of these pathways (Fig. 10,
which is published as supporting information on the PNAS web
site). Addition of the factorsinhibitors in the reverse order, to
determine whether Wnt functioned earlier than activin, also failed
to induce the CD4-Foxa2GFP-Bry population. These data dem-
onstrate the simultaneous requirement of the Wnt and TGF-
nodalactivin pathways for PS formation.
To assess the functional potential of the populations induced in
serum-free cultures, they were evaluated for hematopoietic pro-
genitor content, mesodermal gene expression, and the ability to
generate cells that express endodermmarkers. Populations induced
with low and high concentrations of activin (1 or 25 ngml) or Wnt
(10 and 100 ngml) as well as those induced with the combination
of low concentrations of factors were assayed for hematopoietic
potential. For the hematopoietic progenitor assays, 4-day-old EBs
induced under the above conditions were dispersed and reaggre-
gated overnight in serum-containingmedia. Exposure to serumwas
necessary to obtain hematopoietic colonies, suggesting that factors
present in serum were required to specify mesoderm to a hema-
topoietic fate (9). Populations induced with high concentrations of
Wnt or the combination of low levels of both factors displayed the
greatest hematopoietic potential (Fig. 11A, which is published as
supporting information on the PNAS web site). Wnt or low levels
of activin also induced the expression of the somatic and lateral
plate mesodermmarkersmeox1,meox2, foxc1, and foxc2, indicating
the development of different types ofmesoderm (Fig. 11B) (33–35).
To evaluate endoderm potential, day 6 EBs treated as in Fig. 4A
were plated onto matrigel for 1 week and then assayed for expres-
sion of genes indicative of liver development. In confirmation with
our previous findings, endoderm potential was detected only in the
population induced with high concentrations of activin (data not
shown and ref. 9). Wnt stimulation was unable to induce endoderm
gene expression, a finding consistent with the lack of anterior PS
markers induced by this factor (data not shown and Fig. 4A andC).
The findings from these functional studies demonstrate that dif-
ferent signaling pathways are required for the induction of different
ES cell PS populations.
Activin Stimulation Is Required for Endoderm Development from the
PS. The kinetics of CD4-Foxa2 and GFP-Bry expression shown
in Fig. 4A suggest a developmental progression from CD4hi
GFP-Bry anterior PS population to CD4hi GFP-Bryneg defin-
itive endoderm. To formally demonstrate this transition,
CD4hiGFP cells isolated from day 4 Wntactivin-induced EBs
were reaggregated in the presence or absence of activin (10
ngml) for 2 days (Fig. 5A). Aggregates were plated onto
matrigel for 5 days and analyzed for endoderm gene expression.
The majority of cells aggregated in the presence of activin
displayed a CD4-Foxa2GFP-Bryneg phenotype (Fig. 5A) and
expressed genes indicative of endoderm development after
culture on matrigel (Fig. 5B). In contrast, most of the population
cultured in the absence of activin lost CD4 expression and
generated cells that expressed foxa1 and foxa2, but other genes
indicative of early hepatocyte differentiation, including alb1, aat,
or hnf4, were not found (Fig. 5B). These observations indicate
that TGF-nodalactivin signaling is important for the speci-
fication or maturation of definitive endoderm from the ES cell
anterior PS population. To determine whether this activity of
Fig. 4. Activin and Wnt can induce the development of PS cells in the absence of serum. ES cells were differentiated in serum-free media alone for 2 days. The
EBs were dispersed and reaggregated in serum-free media with activin A (Act; in ngml), Wnt3a (Wnt; in ngml), SB-431542 (SB; inM), and DKK1 (DKK; in ngml)
as indicated. The percentages of CD4hiGFP and CD4lo/medGFP are indicated on the plots. (A) Kinetics of CD4 and GFP expression in cultures induced with activin
or Wnt. (B) Expression of CD4 and GFP in day 4 EB cultures after the indicated treatments. (C) Cells were harvested at the indicated times, and gene-expression
analysis was performed by RT-PCR.
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activin also could induce endoderm from the posterior PS
population, Wntactivin-induced day 4 CD4loGFP cells were
reaggregated in the presence or absence of activin (10 ngml).
Only in the presence of activin did the CD4loGFP cells give rise
to a CD4hiGFPneg population that matured into cells that
expressed genes indicative of endoderm specification (Fig. 5 A
and B). These findings demonstrate that the CD4loGFP cells
induced in serum-free conditions are not yet committed to the
mesoderm lineage and can switch developmental fates after high
levels of activin stimulation.
Discussion
Through the development and use of the CD4-Foxa2GFP-Bry ES
cell line, we were able to identify a CD4-Foxa2GFP-Bry EB
population that shares a number of similarities with the PS of the
mouse embryo. Of particular significance was the observation that
Wnt and activinnodal signaling pathways, which are known to be
required for PS formation in the early embryo (20, 21), also were
required for development of the CD4-Foxa2GFP-Bry popula-
tion. A complete block in Wnt signaling in the early embryo
prevents PS formation, whereas a reduction in signaling in mice
expressing decreased levels of the Wnt coreceptors LPR5 and
LPR6 results in an expansion of the anterior PS population with a
concomitant decrease in the size of the posterior PS (36). This
observation suggests that one of the earliest functions of Wnt
signaling is to establish posterior PS populations. Our finding that
partial Wnt inhibition in the serum-induced cultures resulted in an
increase in the size of the CD4hiGFP population and a decrease
in the size of the CD4loGFP population suggests that Wnt
functions in a similar fashion in vitro. A specific role for Wnt
signaling in the development of this population is provided by our
serum-free experiments that demonstrated that Wnt3a preferen-
tially induced a posterior PS population.
Nodal is a well established regulator of gastrulation and germ-
layer formation in a number of different species. Mutations of the
nodal homologues Squint and Cyclops in zebrafish display a com-
plete loss of endoderm and head and trunk mesoderm (28). In
Xenopus, the nodal related Xnr-1 and Xnr-2 genes can induce
mesoderm in animal cap explant assays in a dose-dependent
manner (37). In addition to the observations that nodal-deficient
mice fail to form a PS, more recent studies have shown that mice
expressing a hypomorphic allele of nodal with decreased signaling
have a truncation of the anteriormesendoderm (38). These findings
suggest that different populations of the PS require different levels
of nodal signaling, with the anterior region requiring the highest.
The inhibition in development of the CD4-Foxa2hiGFP-Bry pop-
ulation in the presence of low levels of the TGF-nodalactivin
inhibitor or by the Smad2 shRNA suggests a similar requirement of
high levels of signaling for its formation in vitro. The most direct
evidence for differential signaling requirements for the induction of
cell types is provided by our serum-free studies, showing that high
amounts of activin induce the anterior PS population, whereas low
concentrations lead to the development of a population with
posterior PS characteristics.
In addition to demonstrating that both Wnt and activin can
induce the CD4-Foxa2GFP-Bry population, our serum-free
studies have shown that the Wnt and TGF-nodalactivin
pathways are required simultaneously at the onset of differen-
tiation. Inhibitors of each pathway blocked the induction by
factors of the other pathway. Together, these observations
indicate that the generation of the PS and its derivatives requires
an interplay between these signaling pathways (Fig. 12, which is
published as supporting information on the PNAS web site).
Although both pathways are required for the initiation of the
development of CD4-Foxa2GFP-Bry cells, they ultimately
induce different populations. Wnt preferentially induces a pos-
terior PS population, whereas activin induces either anterior or
posterior populations, depending on the concentration of factor
used. Collectively, these observations highlight the importance
of understanding the signaling requirements of different lineages
and of using appropriate factors for the generation of specific cell
types in ES cell differentiation cultures.
Materials and Methods
Generation of CD4-Foxa2 Targeted ES Cells. The targeting vector was
constructed by modifying a vector previously used to disrupt the
foxa2 locus (13) (see Supporting Text, which is published as sup-
porting information on the PNASweb site). Themouse ES cell line
GFP-Bry (7) was electroporated with the targeting vector, and
clones that had undergone homologous recombination were iden-
tified by Southern blot analysis.
ES Cell Maintenance. ES cells were maintained either in serum
containing media with feeder cells (7) or in a modified serum-free
feeder-free culture system (39). The serum-free culture media
consisted of 50%Neurobasalmedia (Invitrogen,Carlsbad,CA) and
50% DMEMF12 media mixture (Invitrogen) supplemented with
0.5 of both N2 and B27 supplements (Invitrogen), penicillin,
streptomycin, 0.05% BSA, leukemia inhibitory factor (1% condi-
tioned medium), human bone morphogenic protein 4 (10 ngml;
R & D Systems, Minneapolis, MN), and 1.5  104 M 1-thioglyc-
erol (Sigma, St. Louis, MO).
ES Cell Differentiation. ES cells were differentiated in either serum-
containing media (9) or serum-free media as described below. ES
cells were trypsinized and cultured at 1.5  105 cells per ml in
serum-free differentiation media that consisted of 75% Iscove’s
modified Dulbecco’s medium (Invitrogen) and 25% Ham’s F12
media (Invitrogen) supplemented with 0.5 of both N2 and B27
Fig. 5. Activin induces endoderm formation from CD4GFP cells. ES cells
were differentiated in serum-free cultures in the presence of activin A (2
ngml) and Wnt3a (10 ngml). At day 4, the CD4loGFP and CD4hiGFP cells
were isolated and reaggregated in serum-free media alone or with activin (10
ngml) as indicated. (A) Expression of GFP and CD4 are shown for sorted cells
and 2 days after aggregation. (B) After 2 days of aggregation, aggregates
were plated onto dishes. After 5–7 days of culture, gene expression was
analyzed by RT-PCR.
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(without retinoic acid) supplements (Invitrogen), penicillin, strep-
tomycin, 0.05% BSA, 2 mM glutamine (Invitrogen), 0.5 mM
ascorbic acid (Sigma) and 4.5 104 M 1-thioglycerol. After 48 h,
the EBs were dissociated with trypsin and reaggregated in serum-
free differentiation media with the addition of human activin A,
mouse Wnt3a, human DKK1 (R & D Systems), or SB (Tocris,
Ellisville, MO) as indicated. All data shown are representative
examples of at least three independent experiments unless indicated
otherwise.
Hematopoietic, Cardiac, and Endoderm Assays. For the hematopoi-
etic progenitor assay, EBs induced in various conditions were
dissociated by trypsin into a single-cell suspension and plated in
methylcellulose containing hematopoietic growth factors (9). For
the cardiac assay, cells were reaggregated in Iscove’s modified
Dulbecco’s medium with 15% Knockout Serum Replacement
(Invitrogen), penicillin, streptomycin, 2 mM glutamine, 0.5 mM
ascorbic acid, and 4.5 104M 1-thioglycerol at 1–4 105 cells per
ml in low-cluster tissue-culture dishes (Costar; Corning, Corning,
NY). After 48 h, the aggregates were allowed to adhere onto
matrigel-coated (Becton Dickinson, Franklin Lakes, NJ) dishes in
StemPro 34 (Invitrogen) supplemented with 2 mM glutamine.
After an additional 24–48 h, the proportion of EBs containing
contracting cells was scored. These cultures also were maintained
for 5–7 days, at which time RNA was harvested and analyzed for
endoderm-specific gene expression. For the serum-free induced
cultures, sorted cells were allowed to reaggregate in serum-free
differentiation media as detailed in the results. After 48 h, the EBs
were plated onto matrigel-coated tissue-culture dishes in Iscove’s
modified Dulbecco’s medium with 15% FBS supplemented with 2
mM glutamine and dexamethasone 107 M. After 5–7 days, the
cultures were harvested, and the RNA was isolated.
Embryo Dissections and Explant Cultures. Male GFP-Bry mice on a
mixed genetic background were mated to female Swiss–Webster
mice (Taconic, Hudson, NY). Pregnant mice were killed 7.5 days
after mating, and the embryos were isolated. Dissections were
performed under a fluorescence-equipped dissection microscope
(Leica, Bannockburn, IL) to visualize GFP expression. The
endoderm was stripped from the embryo by mechanical manipu-
lationwith tungsten needles. The PSwas isolated and sectioned into
posterior, middle, and anterior regions as indicated, and gene
expression was analyzed (three to four pieces per group).
Gene-Expression Analysis. For all ES cell-derived cultures, total
RNA was harvested with the RNeasy minikit and treated with
RNase-free DNase (Qiagen, Valencia, CA). Then, 0.5–1 g
of RNA was reverse-transcribed into cDNA by using random
hexamers and SuperScript II reverse transcriptase kit (Invitro-
gen). For the dissected PS pieces, total RNA was harvested with
the RNA-nano kit with RNase-free DNase (Stratagene, La Jolla,
CA), and reverse transcription was performed with random
hexamers by using the Sensiscript reverse transcriptase kit
(Qiagen). The oligonucleotide sequences for actb (actin), aat,
foxa2, hnf4, alb1, brachyury (Bry), pax6, and ipf1 (Pdx1) have
been reported previously (9). Other gene-specific oligonucleo-
tides are listed in the Supporting Text.
Flow Cytometry and Cell Sorting. EBs generated from the CD4-
Foxa2GFP-Bry ES cell line were dissociated by incubation for
1–2 min with trypsin (0.25%)EDTA (Invitrogen) and stained
with anti-human CD4-phycoerythrin or -allophycocyanin
(Caltag, Carlsbad, CA). The cells were acquired by using an LSR
II or FacsCalibur flow cytometer (Becton Dickinson, Franklin
Lakes, NJ) or sorted on a MoFlo cell sorter (Cytomation
Systems, Fort Collins, CO), and analysis including MFI calcu-
lation was performed with FlowJo software (Tree Star, Ashland,
OR).
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